Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | TSPO | P30536 | 1/20 | 0.33 |
| ▸ | PLA2G2A | P14555 | 3/20 | 0.33 |
| ▸ | PLA2G4A | P47712 | 3/20 | 0.33 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.32 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.32 |
| ▸ | EDNRB | P24530 | 1/20 | 0.32 |
| ▸ | EDNRA | P25101 | 1/20 | 0.32 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.32 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.32 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.31 |
| ▸ | BACE1 | P56817 | 1/20 | 0.31 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27253389 | 0.97 | KDM4E (0.38) | KDM4EATML3MBTL1TSPOPLA2G2A | |
| SCHEMBL25852136 | 0.97 | L3MBTL1 (0.41) | KDM4EATML3MBTL1TSPOPLA2G2A | |
| SCHEMBL25789741 | 0.94 | KDM4E (0.41) | KDM4EATML3MBTL1TSPOPLA2G2A | |
| SCHEMBL20633477 | 0.94 | ATM (0.38) | KDM4EATML3MBTL1PLA2G2APLA2G4A | |
| SCHEMBL25941476 | 0.93 | PTGER4 (0.35) | KDM4EATML3MBTL1TSPOPLA2G2A | |
| SCHEMBL25941401 | 0.93 | PTGER4 (0.35) | KDM4EATML3MBTL1TSPOPLA2G2A | |
| SCHEMBL27362232 | 0.92 | EDNRB (0.33) | KDM4EATML3MBTL1TSPOPLA2G2A | |
| SCHEMBL22671690 | 0.92 | KDM4E (0.41) | KDM4EATML3MBTL1TSPOPLA2G2A | |
| SCHEMBL22672362 | 0.92 | KDM4E (0.40) | KDM4EATML3MBTL1TSPOPLA2G2A | |
| SCHEMBL24813227 | 0.92 | PLA2G2A (0.39) | KDM4EATML3MBTL1PLA2G2APLA2G4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024128699-A1 | COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | 삼성에스디아이 주식회사 | 2024-06-20 | — | — | WO | disclosed |
| WO-2024128697-A1 | COMPOSITION FOR OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | 삼성에스디아이 주식회사 | 2024-06-20 | — | — | WO | disclosed |
| EP-4219484-A1 | ORGANIC LIGHT-EMITTING DEVICE, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE | LT Materials Co., Ltd. (KR) | 2023-08-02 | — | — | EP | disclosed |
| US-20230232717-A1 | ORGANIC LIGHT-EMITTING DEVICE, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHTEMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE | LT MATERIALS CO., LTD. (KR) | 2023-07-20 | — | — | US | disclosed |
| US-20230232717-A1 | ORGANIC LIGHT-EMITTING DEVICE, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHTEMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE | LT MATERIALS CO., LTD. (KR) | 2023-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230232717-A1 | ORGANIC LIGHT-EMITTING DEVICE, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHTEMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE | CYBA, AOX1, CYP1A1 | KDM4E 2815/4885ATM 3929/4885L3MBTL1 571/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.